Jim Cramer: Reliance Is ‘Terrific,’ but He Prefers This Steel Stock - Simon Property Group (NYSE:SPG), Nu

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said he is not going to put his money on AstraZeneca PLC (NYSE:AZN) because it has been missing some of its trials.

As per recent news, AstraZeneca on Tuesday secured a key FDA approval for a new breast cancer treatment and reported strong Phase 3 trial data for its lung cancer and respiratory therapies.

Cramer said he has been against Joby Aviation, Inc. (NYSE:JOBY) as it has been losing money. “It’s an interesting spec, but I would not put my money in it,” he added.

On the earnings front, Joby Aviation posted mixed second-quarter results on Aug. 5 and raised its full-year guidance. Joby reported quarterly losses of 25 cents per share, missing the consensus estimate of 23 cents, according to Benzinga Pro data.

Trinity Industries, Inc. (NYSE:TRN) “shouldn’t be down this much,” Cramer said. “Now it’s at a good place. I would pull the trigger.”